Literature DB >> 23430612

Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions.

Janine M van Gils1, Bhama Ramkhelawon, Luciana Fernandes, Merran C Stewart, Liang Guo, Tara Seibert, Gustavo B Menezes, Denise C Cara, Camille Chow, T Bernard Kinane, Edward A Fisher, Mercedes Balcells, Jacqueline Alvarez-Leite, Adam Lacy-Hulbert, Kathryn J Moore.   

Abstract

OBJECTIVE: Emerging evidence suggests that neuronal guidance cues, typically expressed during development, are involved in both physiological and pathological immune responses. We hypothesized that endothelial expression of such guidance cues may regulate leukocyte trafficking into the vascular wall during atherogenesis. APPROACH AND
RESULTS: We demonstrate that members of the netrin, semaphorin, and ephrin family of guidance molecules are differentially regulated under conditions that promote or protect from atherosclerosis. Netrin-1 and semaphorin3A are expressed by coronary artery endothelial cells and potently inhibit chemokine-directed migration of human monocytes. Endothelial expression of these negative guidance cues is downregulated by proatherogenic factors, including oscillatory shear stress and proinflammatory cytokines associated with monocyte entry into the vessel wall. Furthermore, we show using intravital microscopy that inhibition of netrin-1 or semaphorin3A using blocking peptides increases leukocyte adhesion to the endothelium. Unlike netrin-1 and semaphorin3A, the guidance cue ephrinB2 is upregulated under proatherosclerotic flow conditions and functions as a chemoattractant, increasing leukocyte migration in the absence of additional chemokines.
CONCLUSIONS: The concurrent regulation of negative and positive guidance cues may facilitate leukocyte infiltration of the endothelium through a balance between chemoattraction and chemorepulsion. These data indicate a previously unappreciated role for axonal guidance cues in maintaining the endothelial barrier and regulating leukocyte trafficking during atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430612      PMCID: PMC3647028          DOI: 10.1161/ATVBAHA.112.301155

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  28 in total

1.  Neuronal repellent Slit2 inhibits dendritic cell migration and the development of immune responses.

Authors:  Hongbing Guan; Guorui Zu; Yi Xie; Hao Tang; Martin Johnson; Xiaochun Xu; Christophe Kevil; Wen-Cheng Xiong; Craig Elmets; Yi Rao; Jane Y Wu; Hui Xu
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

Review 2.  Intravital microscopy for the study of mouse microcirculation in anti-inflammatory drug research: focus on the mesentery and cremaster preparations.

Authors:  Felicity N E Gavins; Bristi E Chatterjee
Journal:  J Pharmacol Toxicol Methods       Date:  2004 Jan-Feb       Impact factor: 1.950

Review 3.  Mechanisms and molecules of neuronal wiring: a primer.

Authors:  Alex L Kolodkin; Marc Tessier-Lavigne
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

4.  Intravital microscopy on atherosclerosis in apolipoprotein e-deficient mice establishes microvessels as major entry pathways for leukocytes to advanced lesions.

Authors:  Einar E Eriksson
Journal:  Circulation       Date:  2011-10-10       Impact factor: 29.690

5.  Repulsive guidance molecule-A (RGM-A) inhibits leukocyte migration and mitigates inflammation.

Authors:  Valbona Mirakaj; Sebastian Brown; Stefanie Laucher; Carolin Steinl; Gerd Klein; David Köhler; Thomas Skutella; Christian Meisel; Benedikt Brommer; Peter Rosenberger; Jan M Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-05       Impact factor: 11.205

6.  Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model.

Authors:  Sheng-Yu Jin; Junichiro Tohyama; Robert C Bauer; Na Nora Cao; Daniel J Rader; X Long Zheng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-31       Impact factor: 8.311

Review 7.  Endothelial dysfunction, hemodynamic forces, and atherogenesis.

Authors:  M A Gimbrone; J N Topper; T Nagel; K R Anderson; G Garcia-Cardeña
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

Review 8.  Macrophages in the pathogenesis of atherosclerosis.

Authors:  Kathryn J Moore; Ira Tabas
Journal:  Cell       Date:  2011-04-29       Impact factor: 41.582

9.  Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function.

Authors:  Guido Serini; Donatella Valdembri; Sara Zanivan; Giulia Morterra; Constanze Burkhardt; Francesca Caccavari; Luca Zammataro; Luca Primo; Luca Tamagnone; Malcolm Logan; Marc Tessier-Lavigne; Masahiko Taniguchi; Andreas W Püschel; Federico Bussolino
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

10.  The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques.

Authors:  Janine M van Gils; Merran C Derby; Luciana R Fernandes; Bhama Ramkhelawon; Tathagat D Ray; Katey J Rayner; Sajesh Parathath; Emilie Distel; Jessica L Feig; Jacqueline I Alvarez-Leite; Alistair J Rayner; Thomas O McDonald; Kevin D O'Brien; Lynda M Stuart; Edward A Fisher; Adam Lacy-Hulbert; Kathryn J Moore
Journal:  Nat Immunol       Date:  2012-01-08       Impact factor: 25.606

View more
  45 in total

Review 1.  Recent insights into endothelial control of leukocyte extravasation.

Authors:  Peter L Hordijk
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

Review 2.  Macrophages in atherosclerosis: a dynamic balance.

Authors:  Kathryn J Moore; Frederick J Sheedy; Edward A Fisher
Journal:  Nat Rev Immunol       Date:  2013-09-02       Impact factor: 53.106

Review 3.  Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2).

Authors:  Kathryn J Moore; Simon Koplev; Edward A Fisher; Ira Tabas; Johan L M Björkegren; Amanda C Doran; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

4.  RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Christopher J Rhodes; Hogune Im; Aiqin Cao; Jan K Hennigs; Lingli Wang; Silin Sa; Pin-I Chen; Nils P Nickel; Kazuya Miyagawa; Rachel K Hopper; Nancy F Tojais; Caiyun G Li; Mingxia Gu; Edda Spiekerkoetter; Zhaoying Xian; Rui Chen; Mingming Zhao; Mark Kaschwich; Patricia A Del Rosario; Daniel Bernstein; Roham T Zamanian; Joseph C Wu; Michael P Snyder; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2015-08-01       Impact factor: 21.405

Review 5.  Netrins & Semaphorins: Novel regulators of the immune response.

Authors:  Jordyn Feinstein; Bhama Ramkhelawon
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-09-14       Impact factor: 5.187

Review 6.  Targeted Delivery of Shear Stress-Inducible Micrornas by Nanoparticles to Prevent Vulnerable Atherosclerotic Lesions.

Authors:  Wing Tak Wong; Shuangtao Ma; Xiao Yu Tian; Andrea Banuet Gonzalez; Eno E Ebong; Haifa Shen
Journal:  Methodist Debakey Cardiovasc J       Date:  2016-09

Review 7.  Integrin signaling in atherosclerosis.

Authors:  Alexandra C Finney; Karen Y Stokes; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

8.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03

9.  Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival.

Authors:  Bhama Ramkhelawon; Yuan Yang; Janine M van Gils; Bernd Hewing; Katey J Rayner; Sajesh Parathath; Liang Guo; Scott Oldebeken; Jessica L Feig; Edward A Fisher; Kathryn J Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-18       Impact factor: 8.311

10.  Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis.

Authors:  Aránzazu Mediero; Tuere Wilder; Bhama Ramkhelawon; Kathryn J Moore; Bruce N Cronstein
Journal:  FASEB J       Date:  2016-08-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.